… When aPTT waveform analysis was performed on a number of patients with severe hemophilia
A, we found the waveforms differed from patient to patient despite the fact that all were in …

… aPTT clotting assays indicated that the specific activity of factor XI was unaffected by these
treatments. After FPRck and DFP treatments, analysis of residual factor XIa activity was …

… in hemophilia, we compared the spatial dynamics of clotting in platelet-free plasma from
healthy donors and from patients with severe hemophilia … , we determined the APTT in the same …

… This study emphasizes OHP and aPTT-CWA as a powerful laboratory diagnostic tool in
identifying HA patients with unexpected bleeding presentations, with the best results achieved by …

… WB clotting profiles amongst patients with severe hemophilia. … the effect of rFVIIa in hemophilia
A and other rare coagulation … In hemophilia A patients with inhibitor antibodies the APTT …

… hypocoagulability and may be useful in the monitoring of patients with hemophilia. … ) that
made the instrument and APTT reagents used to perform clot waveform measurements in this …

… Patients, method: In this study the feasibility of clot waveform analysis for monitoring of
haemophilia A … The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in …

… The APTT is a clotting time assay that is useful for diagnosing deficiencies in the coagulation
factors of the intrinsic pathway, such as hemophilia, 6 the presence of inhibitors, such as …

… the test citrated plasma sample clots [2]. Thus, clot waveform analysis can be performed at
the same time as the regular clotting end point is determined for the aPTT and PT assays. The …

… APTT is commonplace in patients with severe/moderate hemophilia, a normal APTT may not
exclude mild hemophilia… the sensitivity of the reagent to the particular clotting factor(s). Most …